Visen Pharmaceuticals (2561)
Market Closed
13 Aug, 08:00
HKEX HKEX Primary 19. 98
HKD -0.01
-0.05%
3.5B Market Cap
- P/E Ratio
- Div Yield
96,900 Volume
- Eps
19.99 HKD
Previous Close Want to track 2561 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Visen Pharmaceuticals (2561) Statistics
Valuation metrics
Market Cap 3.5B
Enterprise value 1.39B
Trailing P/E (ttm) -6.95
Forward P/E -9.26
PEG ratio 0.31
Price/Sales (ttm) -735.67
Price/Book (mrq) 2.39
Enterprise Value/Revenue -554.28
Enterprise Value/EBITDA -5.76
Overview
Shares outstanding 109.04M
Float 25.41M
Shares short -
% Held by insiders 0.47%
% Held by institutions 0.47%
Average volume (10 days) 6.7K
Average volume (90 days) 33.45K
Price summary
52-Week low 18.5
52-Week high 50.5
Beta -
50-Day moving average 20.12
200-Day moving average 25.76
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin 100.88%
Operating margin 96.52%
Operational effectiveness
Return on assets -0.26%
Return on equity -0.31%
Income Statement
Revenue (ttm) 156.44K
Revenue per share (ttm) -0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -11.5K
EBITDA -275.05M
Net income to common (ttm) -291.52M
Diluted EPS (ttm) -2.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 727.75M
Total cash per share (mrq) 5.9
Total debt (mrq) 203.59M
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 4.47%
Book value per share (mrq) 7.1
Cash Flow
Cash flow statement -189.43M
Levered free cash flow (LFCF) -253.42M
